Page last updated: 2024-10-19

methylmercaptan and Parkinson Disease

methylmercaptan has been researched along with Parkinson Disease in 1 studies

methylmercaptan: intermediate in the manufacturing of jet fuels, pesticides, fungicides, plastics, synthesis of methionine; odor may cause nausea; narcotic in high concentrations; depresses urea biosynthesis; RN given refers to parent cpd; structure

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbe, AG1
Deutscher, DHC1
Derman, SHM1
Hellmich, M1
Noack, MJ1

Other Studies

1 other study available for methylmercaptan and Parkinson Disease

ArticleYear
Subjective and objective halitosis among patients with Parkinson's disease.
    Gerodontology, 2017, Volume: 34, Issue:4

    Topics: Aged; Case-Control Studies; Female; Halitosis; Humans; Hydrogen Sulfide; Male; Parkinson Disease; Sa

2017